Share-based Payment Arrangement, Expense of ACADIA PHARMACEUTICALS INC from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ACADIA PHARMACEUTICALS INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • ACADIA PHARMACEUTICALS INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $13,180,000, a 50% decline year-over-year.
  • ACADIA PHARMACEUTICALS INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $49,350,000, a 34% decline year-over-year.
  • ACADIA PHARMACEUTICALS INC annual Share-based Payment Arrangement, Expense for 2024 was $67,049,000, a 0.94% increase from 2023.
  • ACADIA PHARMACEUTICALS INC annual Share-based Payment Arrangement, Expense for 2023 was $66,421,000, a 2.6% decline from 2022.
  • ACADIA PHARMACEUTICALS INC annual Share-based Payment Arrangement, Expense for 2022 was $68,201,000, a 7.2% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ACADIA PHARMACEUTICALS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $49,350,000 $13,180,000 -$12,984,000 -50% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $62,334,000 $14,340,000 -$1,345,000 -8.6% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $63,679,000 $11,380,000 -$3,370,000 -23% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $67,049,000 $10,450,000 -$7,573,000 -42% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $74,622,000 $26,164,000 +$7,625,000 +41% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $66,997,000 $15,685,000 +$531,000 +3.5% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $66,466,000 $14,750,000 +$45,000 +0.31% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $66,421,000 $18,023,000 +$3,609,000 +25% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $62,812,000 $18,539,000 +$227,000 +1.2% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $62,585,000 $15,154,000 -$5,358,000 -26% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $67,943,000 $14,705,000 -$258,000 -1.7% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $68,201,000 $14,414,000 +$1,534,000 +12% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $66,667,000 $18,312,000 +$2,766,000 +18% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $63,901,000 $20,512,000 -$1,493,000 -6.8% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $65,394,000 $14,963,000 +$1,779,000 +13% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q4 2021 $63,615,000 $12,880,000 -$8,315,000 -39% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $71,930,000 $15,546,000 -$5,826,000 -27% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $77,756,000 $22,005,000 +$2,498,000 +13% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $75,258,000 $13,184,000 -$9,164,000 -41% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $84,422,000 $21,195,000 +$1,258,000 +6.3% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $83,164,000 $21,372,000 -$651,000 -3% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $83,815,000 $19,507,000 -$915,000 -4.5% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $84,730,000 $22,348,000 +$2,465,000 +12% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $82,265,000 $19,937,000 -$464,000 -2.3% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $82,729,000 $22,023,000 +$1,854,000 +9.2% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020 2020 Q3
Q2 2019 $80,875,000 $20,422,000 -$130,000 -0.63% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $81,005,000 $19,883,000 -$559,000 -2.7% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q4 2018 $81,564,000 $20,401,000 -$1,618,000 -7.3% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q3 2018 $83,182,000 $20,169,000 +$471,000 +2.4% 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019 2019 Q3
Q2 2018 $82,711,000 $20,552,000 +$2,308,000 +13% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019 2019 Q2
Q1 2018 $80,403,000 $20,442,000 +$4,871,000 +31% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019 2019 Q1
Q4 2017 $75,532,000 $22,019,000 +$6,601,000 +43% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
Q3 2017 $68,931,000 $19,698,000 +$5,689,000 +41% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018 2018 Q3
Q2 2017 $63,242,000 $18,244,000 +$4,361,000 +31% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $58,881,000 $15,571,000 +$3,616,000 +30% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q4 2016 $55,265,000 $15,418,000 +$6,516,000 +73% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q3 2016 $48,749,000 $14,009,000 +$4,744,000 +51% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $44,005,000 $13,883,000 +$6,384,000 +85% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $37,621,000 $11,955,000 -$2,573,000 -18% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $40,194,000 $8,902,000 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
Q3 2015 $9,265,000 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 $7,499,000 +$3,199,000 +74% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016 2016 Q2
Q1 2015 $14,528,000 +$11,366,000 +359% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q2 2014 $4,300,000 +$3,200,000 +291% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 $3,162,000 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q2 2013 $1,100,000 01 Apr 2013 30 Jun 2013 10-Q 05 Aug 2014 2014 Q2

ACADIA PHARMACEUTICALS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $67,049,000 +$628,000 +0.94% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $66,421,000 -$1,780,000 -2.6% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $68,201,000 +$4,586,000 +7.2% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $63,615,000 -$20,807,000 -25% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $84,422,000 +$2,157,000 +2.6% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $82,265,000 +$701,000 +0.86% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $81,564,000 +$6,032,000 +8% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $75,532,000 +$20,267,000 +37% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $55,265,000 +$15,071,000 +37% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $40,194,000 +$24,155,000 +151% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $16,039,000 +$10,328,000 +181% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $5,711,000 +$3,781,000 +196% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $1,930,000 01 Jan 2012 31 Dec 2012 10-K 26 Feb 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.